Unicycive Therapeutics (UNCY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

H.C. Wainwright Maintains Buy Rating on Unicycive with $22 Price Target

11:48

Unicycive Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3327 (forecast USD -0.5333)

04:00

Unicycive Therapeutics released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3585

04:00

Oct31

Jason McCarthy Issues a Buy Rating for Unicycive Therapeutics

07:27

Oct29

Unicycive Plans to Resubmit OLC NDA by Year-End

20:39

Aug15

Unicycive Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.49

03:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.011 M, EPS -0.3327

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.447 M, EPS -0.524

Jun20

Reverse Stock Split(EST)

1-for-10 Reverse Stock Split

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change